By Nigam Arora & Dr. Natasha Arora
Signal(s) to enter, add, reduce, exit, hold or change.
Iron Dome
Iron Dome that is protecting Israel from Hamas rockets is in the news these days. RTX is the co-producer of Iron Dome. RTX is also the producer of Patriot Missile System that is protecting Ukraine.
Earnings
Earnings are better than expected. The stock is jumping 7.19% to $78.39 as of this writing on earnings.
Core Model Portfolio
RTX is in the core Model Portfolio. Demand for missile defense systems is insatiable. Defense spending is likely to increase across the globe. RTX is a good way to profit from it.
Zones
For those who are following the Good Way, the Buy Now rating is *** (To see the locked content, please take a 30 day free trial) to start a small scale in. To learn about scaling in, refer to the Trade Management Guidelines.
For those following the Best Way, the buy zone is ***.
The recommended quantity is 35% – 60%.
The very long term target is $152 – $165.
To learn about the Good Way and the Best Way, please read the Getting A Running Start Guide.
This is a very long term position.
What To Do Now
Those in the stock may consider continuing to hold. Those not in the stock may consider following the parameters given above.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
